NuVasive to Present at the 23rd Annual Needham Virtual Growth Conference
NuVasive (NASDAQ: NUVA), a leader in spine technology, announced it will present at the 23rd Annual Needham Virtual Growth Conference on January 14, 2021, at 1:15 p.m. ET. The presentation aims to highlight the company's innovative, minimally disruptive solutions for spine surgery.
A live webcast will be accessible on the Investor Relations page of the company's website, with a replay available for 30 days post-event. NuVasive, with over $1 billion in net sales and operations in over 50 countries, focuses on advancing surgical care.
- None.
- None.
SAN DIEGO, Jan. 7, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 23rd Annual Needham Virtual Growth Conference on Thursday, January 14, 2021 at 1:15 p.m. ET/10:15 a.m. PT.
A live webcast of the presentation will be available online from the Investor Relations page of the Company's website at www.nuvasive.com. A replay of the presentation will remain available on the website for 30 days after the live webcast.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes access, implants and fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA® platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-present-at-the-23rd-annual-needham-virtual-growth-conference-301203031.html
SOURCE NuVasive, Inc.
FAQ
When will NuVasive present at the Needham Growth Conference?
How can I watch NuVasive's presentation at the conference?
What is the focus of NuVasive's presentation?
How long will the replay of NuVasive's conference presentation be available?
What is NuVasive's mission?
